Creative Medical Technology Holdings, Inc. (CELZ) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CELZ Revenue Growth
CELZ Revenue Analysis (2014–2025)
As of May 8, 2026, Creative Medical Technology Holdings, Inc. (CELZ) generated trailing twelve-month (TTM) revenue of $6,000. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, CELZ's 5-year compound annual growth rate (CAGR) stands at -48.4%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $165,500 in 2019.
When compared to Healthcare sector peers including MESO (+191.4% YoY), NKTR (-43.9% YoY), and RCEL (+11.5% YoY). Compare CELZ vs MESO →
CELZ Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CELZCurrent | $6,000 | - | -48.4% | -100324.8% | |
 MESO | $17M | +191.4% | -11.8% | -363.1% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 RCEL | $72M | +11.5% | +19.6% | 89.0% | |
 VCEL | $276M | +22.4% | +17.3% | 4.0% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% |
CELZ Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6K | -45.5% | $4K | 63.4% | $-6,019,487 | -100324.8% |
| 2024 | $11K | +22.2% | $7K | 60.0% | $-5,743,861 | -52216.9% |
| 2023 | $9K | -89.8% | $5K | 60.0% | $-5,620,132 | -62445.9% |
| 2022 | $89K | +1.0% | $60K | 67.8% | $-10,244,372 | -11562.5% |
| 2021 | $88K | -46.7% | $40K | 45.4% | $-3,125,949 | -3562.2% |
| 2020 | $165K | -0.6% | $114K | 69.2% | $-1,114,835 | -677.7% |
| 2019 | $166K | +33.0% | $120K | 72.5% | $-1,130,168 | -682.9% |
| 2018 | $124K | +2491.7% | $54K | 43.4% | $-1,114,225 | -895.7% |
| 2017 | $5K | - | $-3,200 | -66.7% | $-1,177,806 | -24537.6% |
| 2016 | $0 | - | $-766,072 | - | $-766,072 | - |
See CELZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CELZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CELZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCELZ — Frequently Asked Questions
Quick answers to the most common questions about buying CELZ stock.
Is CELZ's revenue growth accelerating or slowing?
CELZ TTM revenue: $6000.00. YoY growth: N/A. 5-year CAGR: -48.4%.
What is CELZ's long-term revenue growth rate?
Creative Medical Technology Holdings, Inc.'s 5-year revenue CAGR of -48.4% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CELZ's revenue distributed by segment?
CELZ reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.